<VariationArchive VariationID="193055" VariationName="NM_000155.4(GALT):c.82+2del" VariationType="Deletion" Accession="VCV000193055" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2015-06-28" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="190220" VariationID="193055">
      <GeneList>
        <Gene Symbol="GALT" FullName="galactose-1-phosphate uridylyltransferase" GeneID="2592" HGNC_ID="HGNC:4135" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34646675" stop="34651035" display_start="34646675" display_stop="34651035" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="34646585" stop="34650594" display_start="34646585" display_stop="34650594" Strand="+" />
          </Location>
          <OMIM>606999</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000155.4(GALT):c.82+2del</Name>
      <CanonicalSPDI>NC_000009.12:34646787:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34646788" stop="34646788" display_start="34646788" display_stop="34646788" variantLength="1" positionVCF="34646787" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="34646785" stop="34646785" display_start="34646785" display_stop="34646785" variantLength="1" positionVCF="34646784" referenceAlleleVCF="GT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.34646785del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.34646785del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.34646788del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.34646788del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009029.2" sequenceAccession="NG_009029" sequenceVersion="2" change="g.5200del">
            <Expression>NG_009029.2:g.5200del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000155.4" sequenceAccession="NM_000155" sequenceVersion="4" change="c.82+2del" MANESelect="true">
            <Expression>NM_000155.4:c.82+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258332.2" sequenceAccession="NM_001258332" sequenceVersion="2" change="c.-121+2del">
            <Expression>NM_001258332.2:c.-121+2del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="794726876" DB="dbSNP" />
        <XRef ID="CA274900" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000155.4(GALT):c.82+2del AND not provided" Accession="RCV000173075" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-04-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000155.4(GALT):c.82+2del AND Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" Accession="RCV003609147" Version="1">
        <ClassifiedConditionList TraitSetID="949">
          <ClassifiedCondition DB="MedGen" ID="C0268151">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-04-09" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-06-28" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16199547</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22944367</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALT</URL>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="949" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5173" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GALACTOSEMIA I</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0015" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Transferase Deficiency Galactosemia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ElementValue>
                <XRef ID="Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206" DB="Genetic Alliance" />
                <XRef ID="124354006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactose-1-phosphate uridyltransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALT deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosemia, classic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term "galactosemia" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia (not covered in this chapter). This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest hypergonadatropic hypogonadism or premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications, including POI.</Attribute>
                <XRef ID="NBK1518" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13639" />
                <XRef ID="13639" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301691</ID>
                <ID Source="BookShelf">NBK1518</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25473725</ID>
                <ID Source="BookShelf">NBK258640</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Hypergalactosemia-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia (Galactose Elevated)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Galactose-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated total galactose with normal GALT enzyme activity, Primary or Secondary Hypergalactosemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Classical-Galactosemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Absent/Reduced Galactose-1-Phosphate Uridyltransferase (GALT), Classic Galactosemia, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/GALT-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Galactosemia (GALT Deficiency), 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Galactosemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Galactosemia (GALT Deficiency, Classical Galactosemia), 2012</CitationText>
              </Citation>
              <XRef ID="352" DB="Orphanet" />
              <XRef ID="79239" DB="Orphanet" />
              <XRef ID="C0268151" DB="MedGen" />
              <XRef ID="MONDO:0009258" DB="MONDO" />
              <XRef Type="MIM" ID="230400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="412463" SubmissionDate="2018-09-19" DateLastUpdated="2015-06-28" DateCreated="2015-06-28">
        <ClinVarSubmissionID localKey="5775_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000224159" DateUpdated="2015-06-28" DateCreated="2015-06-28" Type="SCV" Version="5" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-04-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="-" referenceAllele="T" start="34646785" stop="34646785" variantLength="1" />
            <GeneLocation>NM_000155.3:IVS1</GeneLocation>
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALT</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8242937" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="20757905|MedGen:C0268151" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004454967" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16199547</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22944367</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. ClinVar contains an entry for this variant (Variation ID: 193055). This variant has not been reported in the literature in individuals affected with GALT-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change affects a splice site in intron 1 of the GALT gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in GALT are known to be pathogenic (PMID: 22944367).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.34646785del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268151" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8242937" TraitType="Disease" MappingType="XRef" MappingValue="C0268151" MappingRef="MedGen">
        <MedGen CUI="C0268151" Name="Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="412463" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

